SIGN UP FOR POSTSCARD'S MORNING NEWSLETTER

The best stories of the day, in your inbox

Tata Institute Develops Rs 100 Tablet to Prevent Cancer Recurrence

rs 100 tablet

In a groundbreaking development, Tata Memorial Centre (TMC) has unveiled a remarkable solution to prevent cancer recurrence using an affordable tablet priced at just Rs 100. This breakthrough could revolutionize cancer treatment and significantly impact patients’ lives.

The Rs 100 Tablet: A Game-Changer

The tablet, known as “R+Cu”, promises to be a game-changer in the fight against cancer. When ingested orally, it triggers the production of oxygen radicals in the stomach. These radicals swiftly enter the bloodstream, specifically targeting and destroying harmful cell-free chromatin particles (cfChPs) circulating in the body. By doing so, they effectively halt the spread of cancer cells, known as metastases.

Understanding Cell-Free Chromatin Particles

Cell-free chromatin particles refer to fragments of chromatin—the complex of DNA and proteins that make up chromosomes. These particles are found outside of cells in bodily fluids such as blood or urine. Their presence can serve as valuable biomarkers for various diseases, including cancer. In the case of cancer, dying cancer cells release cfChPs after chemotherapy and radiotherapy. Some of these particles may fuse with healthy chromosomes, potentially causing new tumors.

Affordable Treatment with Far-Reaching Implications

The affordability of the Rs 100 tablet is a significant breakthrough. Currently, cancer treatment costs run into lakhs and crores of rupees, placing a heavy burden on patients and their families. TMC’s research team, led by dedicated doctors and scientists, has worked tirelessly for nearly a decade to develop this cost-effective solution.

Approval and Availability of Rs 100 Tablet

Approval for the Rs 100 tablet is currently awaited from the Food Safety and Standards Authority of India (FSSAI). Once approved, it is expected to be available in the market by June-July 2024. Patients and healthcare professionals alike eagerly anticipate its arrival, as it promises to improve cancer treatment outcomes and reduce the negative effects of conventional therapies like chemotherapy.

A Beacon of Hope

As we await the official green light, the Rs 100 tablet stands as a beacon of hope for cancer patients. Its potential to prevent cancer recurrence by targeting cfChPs could change the landscape of cancer care in India and beyond. The Tata Institute’s commitment to affordable and accessible healthcare continues to inspire us all.

Stay tuned for further updates on this groundbreaking development as we witness science and compassion intersect in the fight against cancer.

Deep Blue Aerospace, a prominent Chinese aerospace company, has set

The Arunachal Pradesh government has launched a comprehensive new tourism

Thailand welcomes an impressive 40 million tourists in 2025, marking

In a landmark event, Prime Minister Narendra Modi inaugurated Mumbai’s

In a bold and optimistic declaration, Sam Altman, CEO of

In a tragic incident that has shocked the Shakarpur community,

In a shocking incident, authorities have arrested a 30-year-old man

In a significant move, the Maharashtra government has approved the

In a dramatic turn of events, Akshay Shinde, the primary

In a shocking and gruesome discovery, the dismembered body of

Anura Kumara Dissanayake, leader of the Marxist-leaning National People’s Power

In an exciting announcement at the RGG Summit 2024, SEGA

In a significant milestone for the economy of India, experts

In a significant move to expand its footprint in the

In a fiery address, Andhra Pradesh Deputy Chief Minister Pawan

In 2023, the Karnataka Milk Federation (KMF) made headlines when

In a shocking incident that has sparked outrage, an army

The controversy surrounding the sacred Tirupati laddoos has taken a

A mysterious virus is spreading across the United States, causing

In a significant policy shift, the Canada government announced new

In a shocking revelation, a recent lab report has confirmed

In a significant diplomatic move, India has formally notified Pakistan,

In a landmark decision, the Union Cabinet has approved the

In a concerning development, a 38-year-old man from Malappuram, Kerala,

Triumph Motorcycles has launched its new Speed T4 in India

Get daily updates in your inbox. Subscribe to our newsletter.